Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: A nested case–control study in the Danish National Birth Cohort

Environmental Health Perspectives

Volumn 123, Issue 4, 2015, Pages 367-373

  Liew, Zeyan ^a   Ritz, Beate ^a,b   von Ehrenstein, Ondine S ^a   Bech, Bodil Hammer ^c   Nohr, Ellen Aagaard ^c,d   Fei, Chunyuan ^e   Bossi, Rossana ^c   Henriksen, Tine Brink ^f   Bonefeld Jørgensen, Eva Cecilie ^g   Olsen, Jørn ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AARHUS UNIVERSITY   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e ABBVIE INC   (United States)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE DERIVATIVE; PERFLUOROALKYL SUBSTANCE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; UNCLASSIFIED DRUG; ALKANESULFONIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE; POLLUTANT;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL PLASMA; PRENATAL EXPOSURE; PRIORITY JOURNAL; SOCIAL STATUS; ADVERSE EFFECTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; BLOOD; CHILD; COHORT ANALYSIS; DENMARK; MATERNAL EXPOSURE; POLLUTANT; PREGNANCY; TOXICITY;

ANIMALIA;

ADULT; ALKANESULFONIC ACIDS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CAPRYLATES; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; DENMARK; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; HUMANS; MALE; MATERNAL EXPOSURE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84926013960     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1408412     Document Type: Article

References (51)

1. Abbott BD, Wolf CJ, Schmid JE, Das KP, Zehr RD, Helfant L, et al. 2007. Perfluorooctanoic acid–induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator–activated receptor-alpha. Toxicol Sci 98:571-581.
2. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. 1999. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46:263-268.
3. Arnold LE. 1996. Sex differences in ADHD: conference summary. J Abnorm Child Psychol 24:555-569.
4. Braun JM, Kalkbrenner AE, Just AC, Yolton K, Calafat AM, Sjödin A, et al. 2014. Gestational exposure to endocrine-disrupting chemicals and reciprocal social, repetitive, and stereotypic behaviors in 4- and 5-year-old children: the HOME study. Environ Health Perspect 122:513-520; doi:10.1289/ehp.1307261.
5. Bech BH, Nohr EA, Vaeth M, Henriksen TB, Olsen J. 2005. Coffee and fetal death: a cohort study with prospective data. Am J Epidemiol 162:983-990.
6. Buck RC, Franklin J, Berger U, Conder JM, Cousins IT, de Voogt P, et al. 2011. Perfluoroalkyl and poly-fluoroalkyl substances in the environment: termi-nology, classification, and origins. Integr Environ Assess Manag 7:513-541.
7. Buck Louis GM, Sundaram R, Schisterman EF, Sweeney AM, Lynch CD, Gore-Langton RE, et al. 2013. Persistent environmental pollutants and couple fecundity: the LIFE study. Environ Health Perspect 121:231-236; doi:10.1289/ehp.1205301.
8. Butenhoff JL, Ehresman DJ, Chang SC, Parker GA, Stump DG. 2009. Gestational and lactational exposure to potassium perfluorooctanesulfonate (K+PFOS) in rats: developmental neurotoxicity. Reprod toxicol 27:319-330.
9. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Tully JS, Needham LL. 2007. Serum concentrations of 11 polyfluoroalkyl compounds in the U.S. popula-tion: data from the National Health and Nutrition Examination Survey (NHANES) 19992000. Environ Sci Technol 41:2237-2242.
10. Darrow LA, Howards PP, Winquist A, Steenland K. 2014. PFOA and PFOS serum levels and miscar-riage risk. Epidemiology 25:505-512.
11. de Cock M, Maas YG, van de Bor M. 2012. Does perinatal exposure to endocrine disruptors induce autism spectrum and attention deficit hyperactivity disorders? Review. Acta Paediatr 101:811-818.
12. D’eon JC, Mabury SA. 2011. Is indirect exposure a significant contributor to the burden of perfluo-rinated acids observed in humans? Environ Sci Technol 45:7974-7984.
13. Ehresman DJ, Froehlich JW, Olsen GW, Chang SC, Butenhoff JL. 2007. Comparison of human whole blood, plasma, and serum matrices for the determi-nation of perfluorooctanesulfonate (PFOS), perfluo-rooctanoate (PFOA), and other fluorochemi cals. Environ Res 103:176-184.
14. Faraone SV, Sergeant J, Gillberg C, Biederman J. 2003. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2:104-113.
15. Fei CY, McLaughlin JK, Lipworth L, Olsen J. 2009. Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod 24:1200-1205.
16. Fei CY, McLaughlin JK, Tarone RE, Olsen J. 2007. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 115:1677-1682; doi:10.1289/ehp.10506.
17. Fei CY, Olsen J. 2011. Prenatal exposure to perfluorinated chemicals and behavioral or coordination problems at age 7 years. Environ Health Perspect 119:573-578; doi:10.1289/ehp.1002026.
18. Glynn A, Berger U, Bignert A, Ullah S, Aune M, Lignell S, et al. 2012. Perfluorinated alkyl acids in blood serum from primiparous women in Sweden: serial sampling during pregnancy and nursing, and temporal trends 19962010. Environ Sci Technol 46:9071-9079.
19. Gump BB, Wu Q, Dumas AK, Kannan K. 2011. Perfluorochemical (PFC) exposure in children: associations with impaired response inhibition. Environ Sci Technol 45:8151-8159.
20. Hertz-Picciotto I, Delwiche L. 2009. The rise in autism and the role of age at diagnosis. Epidemiology 20:84-90.
21. Hoffman K, Webster TF, Weisskopf MG, Weinberg J, Vieira VM. 2010. Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age. Environ Health Perspect 118:1762-1767; doi:10.1289/ehp.1001898.
22. Houde M, Martin JW, Letcher RJ, Solomon KR, Muir DC. 2006. Biological monitoring of polyfluoroalkyl substances: a review. Environ Sci Technol 40:3463-3473.
23. Johansson N, Eriksson P, Viberg H. 2009. Neonatal exposure to PFOS and PFOA in mice results in changes in proteins which are important for neuronal growth and synaptogenesis in the developing brain. Toxicol Sci 108:412-418.
24. Johansson N, Fredriksson A, Eriksson P. 2008. Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neuro-behavioural defects in adult mice. Neurotoxicology 29:160-169.
25. Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM. 2011. Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 19992008. Environ Sci Technol 45:8037-8045.
26. Kjeldsen LS, Bonefeld-Jørgensen EC. 2013. Perfluorinated compounds affect the function of sex hormone receptors. Environ Sci Pollut Res Int 20:8031-8044.
27. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. 2007. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366-394.
28. Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, et al. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation. Toxicol Sci 74:382-392.
29. Lauritsen MB, Jørgensen M, Madsen KM, Lemcke S, Toft S, Grove J, et al. 2010. Validity of childhood autism in the Danish Psychiatric Central Register: findings from a cohort sample born 1990-1999. J Autism Dev Disord 40:139-148.
30. Liew Z, Ritz B, Bonefeld-Jørgensen EC, Henriksen TB, Nohr EA, Bech BH, et al. 2014. Prenatal exposure to perfluoroalkyl substances and the risk of congenital cerebral palsy in children. Am J Epidemiol 180:574-581.
31. Lin CY, Wen LL, Lin LY, Wen TW, Lien GW, Hsu SHJ, et al. 2013. The associations between serum perfluorinated chemicals and thyroid function in adolescents and young adults. J Hazard Mater 244-245:637-644.
32. Long M, Ghisari M, Bonefeld-Jørgensen EC. 2013. Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor. Environ Sci Pollut Res Int 20:8045-8056.
33. Lubin JH, Colt JS, Camann D, Davis S, Cerhan JR, Severson RK, et al. 2004. Epidemiologic evaluation of measurement data in the presence of detec-tion limits. Environ Health Perspect 112:1691-1696; doi:10.1289/ehp.7199.
34. Luebker DJ, York RG, Hansen KJ, Moore JA, Butenhoff JL. 2005. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic param-eters. Toxicology 215:149-169.
35. Lyall K, Schmidt RJ, Hertz-Picciotto I. 2014. Maternal lifestyle and environmental risk factors for autism spectrum disorders. Int J Epidemiol 43:443-464; doi:10.1093/ije/dyt282.
36. Millichap JG. 2008. Etiologic classification of attention- deficit/ hyperactivity disorder. Pediatrics 121:e358-e365.
37. Møller LR, Sørensen MJ, Thomsen PH. 2007. ICD-10 classification in Danish child and adolescent psychiatry—have diagnoses changed after the introduction of ICD-10? Nord J Psychiat 61:7178.
38. Munk-Jørgensen P, Kastrup M, Mortensen PB. 1993. The Danish Psychiatric Register as a tool in epidemiology. Acta Psychiatr Scand Suppl 370:2732.
39. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, et al. 2007. Half-life of serum elimination of perfluorooctanesulfonate, perfluoro hexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115:1298-1305; doi:10.1289/ehp.10009.
40. Olsen J, Melbye M, Olsen SF, Sørensen TI, Aaby P, Andersen AM, et al. 2001. The Danish National Birth Cohort—its background, structure and aim. Scand J Public Health 29:300-307.
41. Pickett J, London E. 2005. The neuropathology of autism: a review. J Neuropathol Exp Neurol 64:925-935.
42. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. 2007. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164:942-948.
43. Polanska K, Jurewicz J, Hanke W. 2012. Exposure to environmental and lifestyle factors and attention- deficit/hyperactivity disorder in children—a review of epidemiological studies. Int J Occup Med Environ Health 25:330-355.
44. Porterfield SP. 2000. Thyroidal dysfunction and environmental chemicals—potential impact on brain development. Environ Health Perspect 108(suppl 3):433-438.
45. Slotkin TA, MacKillop EA, Melnick RL, Thayer KA, Seidler FJ. 2008. Developmental neurotoxicity of perfluorinated chemicals modeled in vitro. Environ Health Perspect 116:716-722; doi:10.1289/ehp.11253.
46. Statens Serum Institut. 2013. Access to DNBC (Danish National Birth Cohort) data. Available: http://www.ssi.dk/English/RandD/Research%20areas/Epidemiology/DNBC/For%20researchers.aspx [accessed 1 April 2013].
47. Stein CR, Savitz DA. 2011. Serum perfluorinated compound concentration and attention deficit/ hyperactivity disorder in children 5-18 years of age. Environ Health Perspect 119:1466-1471; doi:10.1289/ehp.1003538.
48. Stein CR, Savitz DA, Bellinger DC. 2013. Perfluoro-octanoate and neuropsychological outcomes in children. Epidemiology 24:590-599.
49. Viberg H, Lee I, Eriksson P. 2013. Adult dose-dependent behavioral and cognitive disturbances after a single neonatal PFHxS dose. Toxicology 304:185-191.
50. Wang Y, Rogan WJ, Chen PC, Lien GW, Chen HY, Tseng YC, et al. 2014. Association between maternal serum perfluoroalkyl substances during pregnancy and maternal and cord thyroid hormones: Taiwan Maternal and Infant Cohort Study. Environ Health Perspect 122:529-534; doi:10.1289/ehp.1306925.
51. Yuan Y. 2001. Multiple Imputation for Missing Data: Concepts and New Development. Rockville, MD:SAS Institute Inc. Available: https://support.sas.com/rnd/app/stat/papers/multipleimputation.pdf [accessed 18 March 2015].